Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about STERIS plc
STERIS plc News
Jun 13, 2025 - zacks.com
Why Is Steris (STE) Down 1.8% Since Last Earnings Report?
May 21, 2025 - zacks.com
AST Business Growth & Strategic Acquisitions Support STERIS Stock
May 21, 2025 - zacks.com
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
May 20, 2025 - globenewswire.com
U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More
STERIS plc Quantitative Score

About STERIS plc
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
STERIS plc Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
STERIS plc Financials
Table Compare
Compare STE metrics with: | |||
---|---|---|---|
Earnings & Growth | STE | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | STE | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | STE | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | STE | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
STERIS plc Income
STERIS plc Balance Sheet
STERIS plc Cash Flow
STERIS plc Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Buy |
Return on Assets | Strong Buy |
Debt/Equity Ratio | Neutral |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
STERIS plc Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 2.2800 |
Payment Date | Dividend | Frequency |
---|---|---|
2025-06-26 | 0.57 | Quarterly |
2025-03-21 | 0.57 | Quarterly |
2024-12-19 | 0.57 | Quarterly |
2024-09-20 | 0.57 | Quarterly |
2024-06-26 | 0.52 | Quarterly |
Historical Market Cap
Shares Outstanding
STERIS plc Executives
Name | Role |
---|---|
Mr. Daniel A. Carestio | President, Chief Executive Officer & Director |
Mr. Andrew Xilas | Senior Vice President & GM of Dental |
Mr. Michael J. Tokich | Senior Vice President & Chief Financial Officer |
Mr. John Adam Zangerle | Senior Vice President, General Counsel & Secretary |
Mr. Cary L. Majors | Senior Vice President & President of Healthcare |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Daniel A. Carestio | President, Chief Executive Officer & Director | Male | 1973 | 2.17M |
Mr. Andrew Xilas | Senior Vice President & GM of Dental | Male | 1965 | 1.44M |
Mr. Michael J. Tokich | Senior Vice President & Chief Financial Officer | Male | 1969 | 1.03M |
Mr. John Adam Zangerle | Senior Vice President, General Counsel & Secretary | Male | 1967 | 899.11K |
Mr. Cary L. Majors | Senior Vice President & President of Healthcare | Male | 1975 | 796.95K |
STERIS plc Insider Trades
Date | 13 Jun |
Name | Zangerle John Adam |
Role | Sr. VP, Gen Counsel, and Sec. |
Transaction | Disposed |
Type | S-Sale |
Shares | 330 |
Date | 13 Jun |
Name | Zangerle John Adam |
Role | Sr. VP, Gen Counsel, and Sec. |
Transaction | Disposed |
Type | S-Sale |
Shares | 1648 |
Date | 4 Jun |
Name | TOKICH MICHAEL J |
Role | Sr. Vice Pres., CFO |
Transaction | Disposed |
Type | F-InKind |
Shares | 341 |
Date | 4 Jun |
Name | Madsen Julia |
Role | Sr. VP and GM, Life Sciences |
Transaction | Disposed |
Type | F-InKind |
Shares | 194 |
Date | 4 Jun |
Name | Zangerle John Adam |
Role | Sr. VP, Gen Counsel, and Sec. |
Transaction | Disposed |
Type | F-InKind |
Shares | 425 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
13 Jun | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Disposed | S-Sale | 330 |
13 Jun | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Disposed | S-Sale | 1648 |
4 Jun | TOKICH MICHAEL J | Sr. Vice Pres., CFO | Disposed | F-InKind | 341 |
4 Jun | Madsen Julia | Sr. VP and GM, Life Sciences | Disposed | F-InKind | 194 |
4 Jun | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Disposed | F-InKind | 425 |